SCHEMBL5430997

SCHEMBL5430997

Cc1cc(C)cc(C)c1.Cc1ccc(S(=O)(=O)N[C@H]2CCCC[C@@H]2N)cc1.[Ru]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.56
▸ TSHR P16473 2/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ MCOLN2 Q8IZK6 2/20 0.44
▸ MCOLN3 Q8TDD5 2/20 0.44
▸ MCOLN1 Q9GZU1 2/20 0.44
▸ LMNA P02545 3/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ PSEN1 P49768 2/20 0.43
▸ PSEN2 P49810 2/20 0.43
▸ APH1B Q8WW43 2/20 0.43
▸ NCSTN Q92542 2/20 0.43
▸ APH1A Q96BI3 2/20 0.43
▸ PSENEN Q9NZ42 2/20 0.43
▸ TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5422894 1.00 ALDH1A1 (0.56) ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E
P-Xylene SCHEMBL5421280 0.96 ALDH1A1 (0.60) ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E
P-Xylene SCHEMBL5422459 0.96 ALDH1A1 (0.60) ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E
SCHEMBL6816353 0.94 ALDH1A1 (0.62) ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E
SCHEMBL419813 0.94 ALDH1A1 (0.62) ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E
SCHEMBL987578 0.94 ALDH1A1 (0.62) ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E
SCHEMBL810319 0.94 ALDH1A1 (0.62) ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E
M-Xylene SCHEMBL5422493 0.93 ALDH1A1 (0.52) ALDH1A1TSHRCYP3A4SMN1; SMN2MCOLN2
SCHEMBL5433387 0.93 ALDH1A1 (0.52) ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E
M-Xylene SCHEMBL5421549 0.93 ALDH1A1 (0.52) ALDH1A1TSHRCYP3A4SMN1; SMN2MCOLN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7268250-B2 Process for producing optically active compound KANTO KAGAKU KABUSHIKI KAISHA (JP) 2007-09-11 — — US disclosed
US-20040176616-A1 Process for producing optically active compound KANTO KAGAKU KABUSHIKI KAISHA 2004-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176616-A1 Process for producing optically active compound OSTC, NPEPPS, PPOX ALDH1A1 3566/4885TSHR 3616/4885CYP3A4 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback